Pre-SBRT factors | G4-5 RP | G0-3 RP | Total | X2 test | 1-year cumulative incidence of G4-5 RP | log-rank |
---|---|---|---|---|---|---|
Serum KL-6 | Â | Â | Â | Â | Â | Â |
high value | 6 | 17 | 23 | p = 0.0002 | 32% | p < 0.0001 |
within normal level | 2 | 78 | 80 | Â | 3% | Â |
not available | 1 | 13 | 14 | Â | Â | Â |
Serum SP-D | Â | Â | Â | Â | Â | Â |
high value | 5 | 14 | 19 | p = 0.0002 | 29% | p = 0.0001 |
within normal level | 2 | 79 | 81 | Â | 3% | Â |
not available | 2 | 15 | 17 | Â | Â | Â |
IP shadow in CT | Â | Â | Â | Â | Â | Â |
(+) | 7 | 6 | 13 | p < 0.0001 | 57% | p < 0.0001 |
(-) | 2 | 102 | 104 | Â | 2% | Â |